| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2010 | CA2732863A1 A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivatives or their salts, and alendronic acid or its salt |
| 02/04/2010 | CA2732760A1 Pharmaceutical compositions and methods for producing low impurity concentrations of the same |
| 02/04/2010 | CA2732692A1 Pharmaceutical compositions and methods for stabilizing the same |
| 02/04/2010 | CA2732635A1 Curcumin nanoparticles and methods of producing the same |
| 02/04/2010 | CA2732632A1 Psma-binding agents and uses thereof |
| 02/04/2010 | CA2732631A1 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
| 02/04/2010 | CA2732628A1 Therapeutic agents |
| 02/04/2010 | CA2732618A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 02/04/2010 | CA2732513A1 Methods and compositions involving (s)-bucindolol |
| 02/04/2010 | CA2732509A1 Thermochemical ablation system using heat from delivery of electrophiles |
| 02/04/2010 | CA2732497A1 Use of opioids or opioid mimetics for the treatment of resistant cancer patients |
| 02/04/2010 | CA2732437A1 Toll-like receptor agonist formulations and their use |
| 02/04/2010 | CA2732343A1 Selective inhibition of polyglutamine protein expression |
| 02/04/2010 | CA2732336A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | CA2732335A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | CA2732323A1 Tgr5 modulators and methods of use thereof |
| 02/04/2010 | CA2732320A1 A3 adenosine receptor antagonists and partial agonists |
| 02/04/2010 | CA2732307A1 Composition and method for treatment of mrsa |
| 02/04/2010 | CA2732294A1 Accelerated therapy |
| 02/04/2010 | CA2732290A1 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
| 02/04/2010 | CA2732282A1 Aminopropylidene derivative |
| 02/04/2010 | CA2732266A1 Treating various disorders using trkb agonists |
| 02/04/2010 | CA2732232A1 3',6-substituted indirubins and their biological applications |
| 02/04/2010 | CA2732186A1 Imidazothiadiazole derivatives |
| 02/04/2010 | CA2732142A1 Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
| 02/04/2010 | CA2732018A1 Solid pharmaceutical composition |
| 02/04/2010 | CA2731957A1 Nitro derivatives of furasemide and their use as diuretics |
| 02/04/2010 | CA2731939A1 Buprenorphine analogs |
| 02/04/2010 | CA2731919A1 New compounds |
| 02/04/2010 | CA2731909A1 5-alkynyl-pyrimidines |
| 02/04/2010 | CA2731901A1 Nitrogenated derivatives of pancratistatin |
| 02/04/2010 | CA2731873A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 02/04/2010 | CA2731685A1 Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
| 02/04/2010 | CA2731513A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 02/04/2010 | CA2731405A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
| 02/04/2010 | CA2731403A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 02/04/2010 | CA2731378A1 Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome, comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/04/2010 | CA2731209A1 Spiroaminodihydrothiazine derivatives |
| 02/04/2010 | CA2731171A1 Pkc-activating compounds for the treatment of neurodegenerative diseases |
| 02/04/2010 | CA2731165A1 Process for the preparation of o-desmethylvenlafaxine |
| 02/04/2010 | CA2731164A1 Polymorphic form of rasagiline mesylate |
| 02/04/2010 | CA2730774A1 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists |
| 02/04/2010 | CA2730770A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | CA2730489A1 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 02/04/2010 | CA2730441A1 Delivery particle |
| 02/04/2010 | CA2730428A1 Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase |
| 02/04/2010 | CA2730148A1 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
| 02/04/2010 | CA2729581A1 Fluorinated heteroaryls |
| 02/04/2010 | CA2729578A1 Phenanthrenone compounds, compositions and methods |
| 02/04/2010 | CA2729288A1 Administration regime for nitrocatechols |
| 02/04/2010 | CA2729045A1 Pyrimidine compounds, compositions and methods of use |
| 02/04/2010 | CA2728795A1 Use of steroid sulfatase inhibitors for the treatment of preterm labor |
| 02/04/2010 | CA2728096A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/04/2010 | CA2725791A1 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method_______________________ |
| 02/03/2010 | EP2149584A1 Method for enhancing immune response with peptide |
| 02/03/2010 | EP2149580A1 Mimetics of sulfated oligosaccharides |
| 02/03/2010 | EP2149578A1 Novel crystalline polymorphs of clopidogrel |
| 02/03/2010 | EP2149576A1 Isosorbide Nitrates having vasodilating activity |
| 02/03/2010 | EP2149575A1 Diazabicyclic compounds as opioid receptor agonists |
| 02/03/2010 | EP2149574A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof |
| 02/03/2010 | EP2149573A1 Substituted indole sulfonamide compounds their preparation and use as medicaments |
| 02/03/2010 | EP2149571A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| 02/03/2010 | EP2149568A1 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 02/03/2010 | EP2149565A1 Sulfoximine substituted chinazoline derivatives as immune modulators for the treatment of inflammatory and allergic diseases |
| 02/03/2010 | EP2149563A1 Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 02/03/2010 | EP2149562A1 method of preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149560A1 1-substituted tetrahydroisoquinoline compound |
| 02/03/2010 | EP2149558A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 02/03/2010 | EP2149557A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 02/03/2010 | EP2149554A1 Indolyamides as modulators for an EP2 receptor |
| 02/03/2010 | EP2149553A1 3', 6-substituted indirubins and their biological applications |
| 02/03/2010 | EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149550A1 Nitrogen-containing five-membered heterocyclic compound |
| 02/03/2010 | EP2149549A1 Pharmaceutical composition for prevention or treatment of hepatitis |
| 02/03/2010 | EP2149548A1 Method for the chemical synthesis of capsinoids |
| 02/03/2010 | EP2149546A1 Salts of tramadol and ibuprofen and their crystal form in the treatment of pain |
| 02/03/2010 | EP2149382A1 Dentinogenesis promoter and dentinogenic pulp-capping material |
| 02/03/2010 | EP2149376A1 Body-temperature lowering depressant |
| 02/03/2010 | EP2149374A1 Pharmaceutical composition comprising the combinaton of the anti-microbial agent ciprofloxacin and the antioxidant agent ascorbic acid for the treatment of urinary infections |
| 02/03/2010 | EP2149373A1 5HT7 receptor ligands and compositions comprising the same |
| 02/03/2010 | EP2149372A1 Use of opioids or opioid mimetics for the treatment of resistant cancer patients |
| 02/03/2010 | EP2149371A1 Use of steroid sulfatase inhibitors for the treatment of preterm labor |
| 02/03/2010 | EP2149370A1 Diazabicyclic compounds and microemulsions thereof |
| 02/03/2010 | EP2149369A1 Instant oral formulations, gelling at room temperature, useful to treat physical wasting and the depressive syndrome associated with cachexia, anorexia, metabolic disorders, endocrine disorders and dysphagia |
| 02/03/2010 | EP2148931A2 Drug discovery methods for aurora kinase inhibitors |
| 02/03/2010 | EP2148884A1 Antibacterial 1,4,5-substituted aminoglycoside analogs |
| 02/03/2010 | EP2148880A1 P70 s6 kinase inhibitors |
| 02/03/2010 | EP2148879A1 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
| 02/03/2010 | EP2148878A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/03/2010 | EP2148877A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/03/2010 | EP2148876A1 Pyrazolone derivatives as pde4 inhibitors |
| 02/03/2010 | EP2148875A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148874A1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148873A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 02/03/2010 | EP2148872A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 02/03/2010 | EP2148871A1 Quinoline-carboxamide derivatives as p2y12 antagonists |